Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Debt: 2021-2025

Historic Total Debt for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $1.1 billion.

  • Core Scientific's Total Debt rose 123.14% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 123.14%. This contributed to the annual value of $1.1 billion for FY2024, which is 57.00% up from last year.
  • According to the latest figures from Q3 2025, Core Scientific's Total Debt is $1.1 billion, which was up 0.12% from $1.1 billion recorded in Q2 2025.
  • Core Scientific's 5-year Total Debt high stood at $1.1 billion for Q1 2022, and its period low was $45,000 during Q2 2023.
  • Over the past 3 years, Core Scientific's median Total Debt value was $681.8 million (recorded in 2023), while the average stood at $718.4 million.
  • In the last 5 years, Core Scientific's Total Debt plummeted by 99.99% in 2023 and then skyrocketed by 1,170,468.89% in 2024.
  • Core Scientific's Total Debt (Quarterly) stood at $652.2 million in 2021, then tumbled by 65.98% to $5.3 million in 2022, then skyrocketed by 12,753.40% to $684.1 million in 2023, then soared by 57.00% to $1.1 billion in 2024, then skyrocketed by 123.14% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.1 billion during Q1 2025.